Connection
Jesse Schold to Graft vs Host Disease
This is a "connection" page, showing publications Jesse Schold has written about Graft vs Host Disease.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.136 |
|
|
|
-
Reddy V, Winer AG, Eksioglu E, Meier-Kriesche HU, Schold JD, Wingard JR. Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005 Dec; 11(12):1014-21.
Score: 0.056
-
Reddy V, Iturraspe JA, Tzolas AC, Meier-Kriesche HU, Schold J, Wingard JR. Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease. Blood. 2004 Jun 01; 103(11):4330-5.
Score: 0.049
-
Dunbar EM, Buzzeo MP, Levine JB, Schold JD, Meier-Kriesche HU, Reddy V. The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease. Haematologica. 2008 Dec; 93(12):1852-8.
Score: 0.017
-
Reddy V, Meier-Kriesche HU, Greene S, Schold JD, Wingard JR. Increased levels of tumor necrosis factor alpha are associated with an increased risk of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005 Sep; 11(9):698-705.
Score: 0.014